Literature DB >> 24682138

Double trouble: hypertrophic cardiomyopathy coexistent with malignant anomalous right coronary artery.

Stephen Liddy1, Andrew K Roy, Charles McCreery.   

Abstract

A 40-year-old man with no cardiac history was admitted for evaluation of atypical chest pain of 1-month duration. On investigation he was found to have hypertrophic cardiomyopathy and an anomalous right coronary artery arising from the left sinus of Valsalva. This is of great clinical significance as both these conditions are independently associated with sudden cardiac death. Following extensive risk assessment and detailed discussion with the patient, he was discharged on medical therapy, comprising bisoprolol, aspirin and rosuvastatin. He has remained free of symptoms for 1 year. This report describes the rare coexistence of these two distinct clinical entities, examines the various treatment options and provides support for medical management as an acceptable treatment strategy in appropriately selected cases.

Entities:  

Mesh:

Year:  2014        PMID: 24682138      PMCID: PMC3975521          DOI: 10.1136/bcr-2013-203344

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Six-month success of intracoronary stenting for anomalous coronary arteries associated with myocardial ischemia.

Authors:  A J Doorey; M J Pasquale; J F Lally; G S Mintz; E Marshall; D A Ramos
Journal:  Am J Cardiol       Date:  2000-09-01       Impact factor: 2.778

2.  Hypertrophic obstructive cardiomyopathy and anomalous origin of the right coronary artery. A rare coexistence.

Authors:  Paweł Tyczyński; Artur Dębski; Jerzy Pręgowski; Lidia Chojnowska; Adam Witkowski
Journal:  Kardiol Pol       Date:  2013       Impact factor: 3.108

Review 3.  Hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Martin S Maron
Journal:  Lancet       Date:  2012-08-06       Impact factor: 79.321

4.  Anomalous origin of right coronary artery associated with hypertrophic obstructive cardiomyopathy.

Authors:  Ankush Moza; Rohini Prashar; Muhammad Bawany
Journal:  Am J Med Sci       Date:  2011-10       Impact factor: 2.378

5.  Clinical features of prognosis of Japanese patients with anomalous origin of the coronary artery.

Authors:  B Kaku; M Shimizu; H Yoshio; H Ino; S Mizuno; H Kanaya; S Ishise; H Mabuchi
Journal:  Jpn Circ J       Date:  1996-10

6.  Congenital anomalous aortic origins of the coronary arteries in adults: a Tunisian coronary arteriography study.

Authors:  Sana Ouali; Elyes Neffeti; Karim Sendid; Karima Elghoul; Fahmi Remedi; Essia Boughzela
Journal:  Arch Cardiovasc Dis       Date:  2009-03-17       Impact factor: 2.340

7.  ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Carole A Warnes; Roberta G Williams; Thomas M Bashore; John S Child; Heidi M Connolly; Joseph A Dearani; Pedro Del Nido; James W Fasules; Thomas P Graham; Ziyad M Hijazi; Sharon A Hunt; Mary Etta King; Michael J Landzberg; Pamela D Miner; Martha J Radford; Edward P Walsh; Gary D Webb
Journal:  J Am Coll Cardiol       Date:  2008-12-02       Impact factor: 24.094

Review 8.  Hypertrophic cardiomyopathy associated with an anomalous origin of right coronary artery. Case report and review of the literature.

Authors:  G K Efthimiadis; E K Theofilogiannakos; T D Gossios; S Paraskevaidis; V P Vassilikos; I H Styliadis
Journal:  Herz       Date:  2012-12-23       Impact factor: 1.443

Review 9.  Anomalous aortic origin of coronary arteries from the opposite sinus: a critical appraisal of risk.

Authors:  Josiah M Peñalver; Ralph S Mosca; Daniel Weitz; Colin K L Phoon
Journal:  BMC Cardiovasc Disord       Date:  2012-10-01       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.